Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Cash & Equivalents (2018 - 2025)

Verastem (VSTM) has 8 years of Cash & Equivalents data on record, last reported at $205.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 130.8% year-over-year to $205.0 million; the TTM value through Dec 2025 reached $205.0 million, up 130.8%, while the annual FY2025 figure was $205.0 million, 130.8% up from the prior year.
  • Cash & Equivalents reached $205.0 million in Q4 2025 per VSTM's latest filing, up from $137.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $205.0 million in Q4 2025 and bottomed at $995000.0 in Q4 2021.
  • Average Cash & Equivalents over 5 years is $89.9 million, with a median of $82.3 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: crashed 98.53% in 2021, then skyrocketed 7847.34% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $995000.0 in 2021, then surged by 7847.34% to $79.1 million in 2022, then decreased by 1.48% to $77.9 million in 2023, then rose by 14.0% to $88.8 million in 2024, then soared by 130.8% to $205.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $205.0 million in Q4 2025, $137.7 million in Q3 2025, and $164.3 million in Q2 2025.